RVVTF
Price:
$0.0075
Market Cap:
$4.39M
Revive Therapeutics Ltd., a life sciences company, focuses on the research and development of therapeutics for rare disorders and infectious diseases. The company offers cannabinoid pharmaceutical portfolio that focuses on rare inflammatory diseases. It is developing Bucillamine, which is in Phase 3 clinical study for the treatment of infectious diseases, including influenza and COVID-19; Psilocybin that is in Phase 1 clinical study for treating methamphetamine use disorder; Psilocin for the treatment of depression, anxiety, bi-polar disorder, bulimia and anorexia nervosa, and other diseases; and cannabidiol for treating autoimmune hepatitis and ischemia and reperfusion injury from organ tra...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2015-12-02
Stock Exchange
PNK
Ticker
RVVTF
According to Revive Therapeutics Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 3.64M. This represents a change of -60.96% compared to the average of 9.33M of the last 4 quarters.
The mean historical Enterprise Value of Revive Therapeutics Ltd. over the last ten years is 36.25M. The current 3.64M Enterprise Value has changed 904.25% with respect to the historical average. Over the past ten years (40 quarters), RVVTF's Enterprise Value was at its highest in in the June 2021 quarter at 169.05M. The Enterprise Value was at its lowest in in the June 2016 quarter at 1.17M.
Average
36.25M
Median
10.87M
Minimum
-747850.00
Maximum
140.48M
Discovering the peaks and valleys of Revive Therapeutics Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 618.97%
Maximum Annual Enterprise Value = 140.48M
Minimum Annual Increase = -104.87%
Minimum Annual Enterprise Value = -747850.00
Year | Enterprise Value | Change |
---|---|---|
2024 | -747850.00 | -104.87% |
2023 | 15.34M | -89.08% |
2022 | 140.48M | 0.59% |
2021 | 139.65M | 367.08% |
2020 | 29.90M | 354.20% |
2019 | 6.58M | -34.79% |
2018 | 10.09M | 19.73% |
2017 | 8.43M | 618.97% |
2016 | 1.17M | -89.92% |
2015 | 11.64M | 13.61% |
The current Enterprise Value of Revive Therapeutics Ltd. (RVVTF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
51.69M
5-year avg
64.92M
10-year avg
36.25M
Revive Therapeutics Ltd.’s Enterprise Value is less than THC Biomed Intl Ltd. (3.28B), less than Vext Science, Inc. (66.76M), less than New Leaf Ventures Inc (5.34M), greater than Pharmadrug Inc. (2.82M), greater than High Fusion Inc. (1.07M), greater than Green Cures & Botanical Distribution Inc. (528.02K), less than Nextleaf Solutions Ltd. (12.23M), greater than GelStat Corporation (837.32K), less than Levitee Labs Inc. (1.23B), greater than Choom Holdings Inc. (1.78M), less than Avicanna Inc. (29.57M), greater than Wayland Group Corp. (-893311.00), less than CV Sciences, Inc. (5.93M), less than Columbia Care Inc. (1.04B), less than Trulieve Cannabis Corp. (1.70B), less than Curaleaf Holdings, Inc. (2.23B), less than Green Thumb Industries Inc. (2.50B), less than The BC Bud Corporation (4.86M), greater than Amexdrug Corporation (615.36K), less than Aion Therapeutic Inc. (9.11M), less than Aspen Pharmacare Holdings Limited (29.56B), less than Antisense Therapeutics Limited (18.36M),
Company | Enterprise Value | Market cap |
---|---|---|
3.28B | $2.35B | |
66.76M | $31.69M | |
5.34M | $993.67K | |
2.82M | $1.10M | |
1.07M | $767.56K | |
528.02K | $522.63K | |
12.23M | $8.92M | |
837.32K | $247.19K | |
1.23B | $878.23M | |
1.78M | $1.78M | |
29.57M | $20.38M | |
-893311.00 | $23.70K | |
5.93M | $6.82M | |
1.04B | $521.35M | |
1.70B | $1.12B | |
2.23B | $1.47B | |
2.50B | $2.14B | |
4.86M | $3.31M | |
615.36K | $338.82K | |
9.11M | $5.08M | |
29.56B | $5.44B | |
18.36M | $19.64M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Revive Therapeutics Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Revive Therapeutics Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Revive Therapeutics Ltd.'s Enterprise Value?
What is the highest Enterprise Value for Revive Therapeutics Ltd. (RVVTF)?
What is the 3-year average Enterprise Value for Revive Therapeutics Ltd. (RVVTF)?
What is the 5-year average Enterprise Value for Revive Therapeutics Ltd. (RVVTF)?
How does the current Enterprise Value for Revive Therapeutics Ltd. (RVVTF) compare to its historical average?